Infokiri

Dokumendiregister	Terviseamet
Viit	13.2-7/24/2547-1
Registreeritud	05.03.2024
Sünkroonitud	26.03.2024
Liik	Sissetulev dokument
Funktsioon	13.2 Nakkushaiguste labor
Sari	13.2-7 NHL kirjavahetus
Toimik	13.2-7/2024
Juurdepääsupiirang	Avalik
Juurdepääsupiirang
Adressaat	WHO
Saabumis/saatmisviis	WHO
Vastutaja	Oksana Joamets (TA, Peadirektori asetäitja (2) vastutusvaldkond, Rahvatervise labor, Nakkushaiguste labor)
Originaal	Ava uues aknas

Failid

GMRLN guidance for use of extended sequencing of measles virus for the verification of elimination (February 2024).msg

image001.png

GMRLN guidance for use of extended sequencing of measles virus for the verification of elimination (February 2024).msg

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.

Dear all,

Please be informed the guidance on Use of extended sequencing of measles virus for the verification of elimination presented in October 2023 in Istanbul is now published in the WHO Laboratory Manual at this link.

Best regards,

Myriam

Myriam Ben Mamou, MD, medical virologist.

Technical Officer, Measles & Rubella Laboratory - Disease Control and Elimination (DCE)

Vaccine-preventable Diseases and Immunization (VIF)

Division of Country Health Programmes (CHP)

UN City, Marmorvej 51

DK-2100 Copenhagen, Denmark

Tel.: +45 45 33 69 20 gpn 76920

Mob.: +45 40 48 49 18

E-mail: [email protected]

Essential guidelines and resources

- Manual for the Laboratory-based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome

- WHO MR LabNet protocols

- Eliminating measles and rubella in the WHO European Region: integrated guidance for surveillance, outbreak response and verification of elimination

- Vaccine-preventable diseases and Immunization webpage, WHO European Region

- WHO Vaccine-preventable diseases surveillance guidelines: Measles ; Rubella ; CRS

image001.png